Takeda To Build Dengue Vaccine Manufacturing Plant in Germany

Headquartered in Japan, Takeda Pharmaceutical Company Ltd. is the largest pharmaceutical company in Asia and is speeding up development of a vaccine for dengue fever—a mosquito-borne flavivirus disease.1 The Japanese drugmaker has initiated a 20,000 patient based Phase 3 study in Asia and Latin America to test its TAK-003 experimental dengue vaccine

Click this link to read the full story: Takeda To Build Dengue Vaccine Manufacturing Plant in Germany

Please follow and like us:

Related Post

Leave a Reply